Direxion Daily S&P Biotech Bull 3X Shares (LABU) delivered 235% returns over the past year versus 65% for the underlying XBI biotech ETF by leveraging daily gains, but the fund is down 87% over five ...
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have ...
The Direxion Daily S&P Biotech Bull 3X Shares ETF (LABU) offers 3x daily leveraged exposure to the S&P Biotechnology Select Industry Index. LABU is highly liquid and popular among short-term traders, ...
With Biotech stocks running into a speed-bump in the past couple sessions including today, we have seen some liquidations in the levered long LABU (Direxion Daily S&P Biotech Bull 3X, Expense Ratio ...
The coronavirus pandemic is fueling gains for biotechnology exchange traded funds this year and the leverage members of this group are participating in the fun. “Despite its growth image, the ...
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3X Shares (Symbol: LABU) where we have ...
The Direxion Daily S&P Biotech Bull 3X Shares (NYSEARCA: LABU) and Direxion Daily S&P Biotech Bear 3X Shares (NYSEARCA: LABD) ETFs have their place in a trading strategy. They can even be used as very ...
Sean Ross is a strategic adviser at 1031x.com, Investopedia contributor, and the founder and manager of Free Lances Ltd. The Direxion Daily S&P Biotech Bull 3X Fund (NYSEARCA: LABU) is an exchange ...
If you bought XBI a year ago and held it, you are up roughly 65%. If you bought Direxion Daily S&P Biotech Bull 3X Shares (NYSEARCA:LABU) on the same day, you are up about 235%. That is the pitch for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results